{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T23:36:27Z","timestamp":1794612987561,"version":"4.9.1"},"reference-count":69,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,9,22]],"date-time":"2023-09-22T00:00:00Z","timestamp":1695340800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,9,22]],"date-time":"2023-09-22T00:00:00Z","timestamp":1695340800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100007176","name":"Scuola Superiore Sant'Anna","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100007176","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Heart Fail Rev"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Cardiac amyloidosis (CA) is an underdiagnosed condition caused by the deposition of misfolded proteins, namely immunoglobulin light chains and transthyretin, in the extracellular spaces of the heart. Any cardiovascular structure can be affected by amyloid infiltration, including the valves. Amyloid accumulation within the cardiac valves may lead to their structural and functional impairment, with a profound impact on patients\u2019 prognosis and quality of life. The most common forms of valvular disease in CA are aortic stenosis (AS), mitral regurgitation (MR), and tricuspid regurgitation (TR). CA and AS share similar risk factors, disease mechanisms, and remodeling patterns, which make their diagnosis particularly challenging. Patients with both CA and AS experience worse outcomes than CA or AS alone, and transcatheter aortic valve replacement may represent a useful therapeutic strategy in this population. Data on MR and TR are quite limited and mainly coming from case reports or small series. This review paper will summarize our current understanding on the epidemiology, disease mechanisms, echocardiographic features, clinical implications, and therapeutic options of AS, MR, and TR in patients with CA.<\/jats:p>","DOI":"10.1007\/s10741-023-10350-1","type":"journal-article","created":{"date-parts":[[2023,9,22]],"date-time":"2023-09-22T03:27:11Z","timestamp":1695353231000},"page":"65-77","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":41,"title":["Valvular heart disease in patients with cardiac amyloidosis"],"prefix":"10.1007","volume":"29","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9129-9519","authenticated-orcid":false,"given":"Alberto","family":"Aimo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lara","family":"Camerini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iacopo","family":"Fabiani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paolo","family":"Morfino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giorgia","family":"Panichella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Barison","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angela","family":"Pucci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincenzo","family":"Castiglione","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Vergaro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gianfranco","family":"Sinagra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michele","family":"Emdin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,9,22]]},"reference":[{"key":"10350_CR1","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/j.ijcard.2019.07.051","volume":"300","author":"N Maurizi","year":"2020","unstructured":"Maurizi N, Rella V, Fumagalli C, Salerno S, Castelletti S, Dagradi F et al (2020) Prevalence of cardiac amyloidosis among adult patients referred to tertiary centres with an initial diagnosis of hypertrophic cardiomyopathy. Int J Cardiol 300:191\u20135","journal-title":"Int J Cardiol"},{"issue":"45","key":"10350_CR2","doi-asserted-by":"publisher","first-page":"3699","DOI":"10.1093\/eurheartj\/ehz298","volume":"40","author":"M Emdin","year":"2019","unstructured":"Emdin M, Aimo A, Rapezzi C, Fontana M, Perfetto F, Seferovi\u0107 PM et al (2019) Treatment of cardiac transthyretin amyloidosis: an update. Eur Heart J 40(45):3699\u2013706","journal-title":"Eur Heart J"},{"issue":"24","key":"10350_CR3","doi-asserted-by":"publisher","first-page":"2404","DOI":"10.1161\/CIRCULATIONAHA.116.021612","volume":"133","author":"JD Gillmore","year":"2016","unstructured":"Gillmore JD, Maurer MS, Falk RH, Merlini G, Damy T, Dispenzieri A et al (2016) Nonbiopsy diagnosis of cardiac transthyretin amyloidosis. Circulation 133(24):2404\u201312","journal-title":"Circulation"},{"issue":"2","key":"10350_CR4","first-page":"133","volume":"20","author":"M Fontana","year":"2015","unstructured":"Fontana M, Chung R, Hawkins PN, Moon JC (2015) Cardiovascular magnetic resonance for amyloidosis. Heart Fail\u00a0Rev 20(2):133\u201344","journal-title":"Heart Fail\u00a0Rev"},{"key":"10350_CR5","doi-asserted-by":"publisher","first-page":"1073503","DOI":"10.3389\/fcvm.2022.1073503","volume":"9","author":"CC Quarta","year":"2022","unstructured":"Quarta CC, Fontana M, Damy T, Catini J, Simoneau D, Mercuri M et al (2022) Changing paradigm in the treatment of amyloidosis: from disease-modifying drugs to anti-fibril therapy. Front Cardiovasc Med 9:1073503","journal-title":"Front Cardiovasc Med"},{"issue":"45","key":"10350_CR6","doi-asserted-by":"publisher","first-page":"4679","DOI":"10.1093\/eurheartj\/ehac543","volume":"43","author":"C Rapezzi","year":"2022","unstructured":"Rapezzi C, Aimo A, Barison A, Emdin M, Porcari A, Linhart A et al (2022) Restrictive cardiomyopathy: definition and diagnosis. Eur Heart J 43(45):4679\u201393","journal-title":"Eur Heart J"},{"issue":"25 Pt A","key":"10350_CR7","doi-asserted-by":"publisher","first-page":"2852","DOI":"10.1016\/j.jacc.2014.04.018","volume":"63","author":"S Coffey","year":"2014","unstructured":"Coffey S, Cox B, Williams MJ (2014) The prevalence, incidence, progression, and risks of aortic valve sclerosis: a systematic review and meta-analysis. J Am Coll Cardiol 63(25 Pt A):2852\u20132861","journal-title":"J Am Coll Cardiol"},{"issue":"1","key":"10350_CR8","first-page":"32","volume":"17","author":"G Pesk\u00f3","year":"2019","unstructured":"Pesk\u00f3 G, Jenei Z, Varga G, Apor A, V\u00e1g\u00f3 H, Czibor S et al (2019) Coexistence of aortic valve stenosis and cardiac amyloidosis: echocardiographic and clinical significance. Cardiovasc\u00a0Ultrasound 17(1):32","journal-title":"Cardiovasc\u00a0Ultrasound"},{"issue":"38","key":"10350_CR9","doi-asserted-by":"publisher","first-page":"2879","DOI":"10.1093\/eurheartj\/ehx350","volume":"38","author":"A Casta\u00f1o","year":"2017","unstructured":"Casta\u00f1o A, Narotsky DL, Hamid N, Khalique OK, Morgenstern R, DeLuca A et al (2017) Unveiling transthyretin cardiac amyloidosis and its predictors among elderly patients with severe aortic stenosis undergoing transcatheter aortic valve replacement. Eur Heart J 38(38):2879\u201387","journal-title":"Eur Heart J"},{"issue":"4","key":"10350_CR10","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1016\/j.jacc.2017.11.037","volume":"71","author":"PR Scully","year":"2018","unstructured":"Scully PR, Treibel TA, Fontana M, Lloyd G, Mullen M, Pugliese F et al (2018) Prevalence of cardiac amyloidosis in patients referred for transcatheter aortic valve replacement. J Am Coll Cardiol 71(4):463\u20134","journal-title":"J Am Coll Cardiol"},{"key":"10350_CR11","doi-asserted-by":"publisher","unstructured":"Treibel TA, Fontana M, Gilbertson JA, Castelletti S, White SK, Scully PR et al (2016) Occult transthyretin cardiac amyloid in severe calcific aortic stenosis: prevalence and prognosis in patients undergoing surgical aortic valve replacement. Circ\u00a0Cardiovasc imaging 9(8):e005066. https:\/\/doi.org\/10.1161\/CIRCIMAGING.116.005066. PMID: 27511979.","DOI":"10.1161\/CIRCIMAGING.116.005066"},{"issue":"3","key":"10350_CR12","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1016\/j.jcmg.2015.04.012","volume":"9","author":"S Longhi","year":"2016","unstructured":"Longhi S, Lorenzini M, Gagliardi C, Milandri A, Marzocchi A, Marrozzini C et al (2016) Coexistence of degenerative aortic stenosis and wild-type transthyretin-related cardiac amyloidosis. JACC Cardiovasc Imaging 9(3):325\u20137","journal-title":"JACC Cardiovasc Imaging"},{"issue":"4","key":"10350_CR13","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1016\/j.jaccao.2021.08.008","volume":"3","author":"AK Singal","year":"2021","unstructured":"Singal AK, Bansal R, Singh A, Dorbala S, Sharma G, Gupta K et al (2021) Concomitant transthyretin amyloidosis and severe aortic stenosis in elderly Indian population: a pilot study. JACC CardioOncology. 3(4):565\u201376","journal-title":"JACC CardioOncology."},{"issue":"21","key":"10350_CR14","first-page":"2638","volume":"74","author":"J Ternacle","year":"2019","unstructured":"Ternacle J, Krapf L, Mohty D, Magne J, Nguyen A, Galat A et al (2019) Aortic stenosis and cardiac amyloidosis: JACC review topic of the week. J\u00a0Am\u00a0Coll\u00a0Cardiol 74(21):2638\u201351","journal-title":"J\u00a0Am\u00a0Coll\u00a0Cardiol"},{"issue":"12","key":"10350_CR15","doi-asserted-by":"publisher","first-page":"2342","DOI":"10.1002\/ejhf.2532","volume":"24","author":"A Aimo","year":"2022","unstructured":"Aimo A, Merlo M, Porcari A, Georgiopoulos G, Pagura L, Vergaro G et al (2022) Redefining the epidemiology of cardiac amyloidosis a systematic review and meta-analysis of screening studies. Eur Heart J Fail 24(12):2342\u20132351","journal-title":"Eur Heart J Fail"},{"issue":"10","key":"10350_CR16","doi-asserted-by":"publisher","first-page":"1852","DOI":"10.1002\/ejhf.1756","volume":"22","author":"C Nitsche","year":"2020","unstructured":"Nitsche C, Aschauer S, Kammerlander AA, Schneider M, Poschner T, Duca F et al (2020) Light-chain and transthyretin cardiac amyloidosis in severe aortic stenosis: prevalence, screening possibilities, and outcome. Eur J Heart Fail 22(10):1852\u201362","journal-title":"Eur J Heart Fail"},{"issue":"2","key":"10350_CR17","first-page":"128","volume":"77","author":"C Nitsche","year":"2021","unstructured":"Nitsche C, Scully PR, Patel KP, Kammerlander AA, Koschutnik M, Dona C et al (2021) Prevalence and outcomes of concomitant aortic stenosis and cardiac amyloidosis. J\u00a0Am\u00a0Coll\u00a0Cardiol 77(2):128\u201339","journal-title":"J\u00a0Am\u00a0Coll\u00a0Cardiol"},{"issue":"10","key":"10350_CR18","doi-asserted-by":"publisher","first-page":"1337","DOI":"10.15252\/emmm.201505357","volume":"7","author":"J Marcoux","year":"2015","unstructured":"Marcoux J, Mangione PP, Porcari R, Degiacomi MT, Verona G, Taylor GW et al (2015) A novel mechano-enzymatic cleavage mechanism underlies transthyretin amyloidogenesis. EMBO Mol Med 7(10):1337\u201349","journal-title":"EMBO Mol Med"},{"key":"10350_CR19","doi-asserted-by":"publisher","unstructured":"Cantarutti C, Mimmi MC, Verona G, Mandaliti W, Taylor GW, Mangione PP et al (2022) Calcium binds to transthyretin with low affinity. Biomolecules 12(8):1066. https:\/\/doi.org\/10.3390\/biom12081066. PMID: 36008960; PMCID: PMC9406000.","DOI":"10.3390\/biom12081066"},{"key":"10350_CR20","doi-asserted-by":"publisher","unstructured":"Sud K, Narula N, Aikawa E, Arbustini E, Pibarot P, Merlini G et al (2023) The contribution of amyloid deposition in the aortic valve to calcification and aortic stenosis. Nat Rev Cardiol 20(6):418\u2013428. https:\/\/doi.org\/10.1038\/s41569-022-00818-2. Epub 2023 Jan 9. Erratum in: Nat Rev Cardiol. 2023 Feb 17;: PMID: 36624274; PMCID: PMC10199673.","DOI":"10.1038\/s41569-022-00818-2"},{"issue":"9","key":"10350_CR21","doi-asserted-by":"publisher","first-page":"e006075","DOI":"10.1161\/CIRCHEARTFAILURE.119.006075","volume":"12","author":"MS Maurer","year":"2019","unstructured":"Maurer MS, Bokhari S, Damy T, Dorbala S, Drachman BM, Fontana M et al (2019) Expert consensus recommendations for the suspicion and diagnosis of transthyretin cardiac amyloidosis. Circ\u00a0Heart Fail 12(9):e006075","journal-title":"Circ\u00a0Heart Fail"},{"issue":"1","key":"10350_CR22","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1038\/s41572-018-0034-3","volume":"4","author":"G Merlini","year":"2018","unstructured":"Merlini G, Dispenzieri A, Sanchorawala V, Sch\u00f6nland SO, Palladini G, Hawkins PN et al (2018) Systemic immunoglobulin light chain amyloidosis. Nat Rev Dis Primers 4(1):38","journal-title":"Nat Rev Dis Primers"},{"issue":"3","key":"10350_CR23","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1002\/ejhf.2769","volume":"25","author":"G Vergaro","year":"2023","unstructured":"Vergaro G, Castiglione V, Aimo A, Prontera C, Masotti S, Musetti V et al (2023) N-terminal pro-B-type natriuretic peptide and high-sensitivity troponin T hold diagnostic value in cardiac amyloidosis. Eur J Heart Fail 25(3):335\u201346","journal-title":"Eur J Heart Fail"},{"issue":"2","key":"10350_CR24","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.tcm.2018.06.011","volume":"29","author":"CX Tang","year":"2019","unstructured":"Tang CX, Petersen SE, Sanghvi MM, Lu GM, Zhang LJ (2019) Cardiovascular magnetic resonance imaging for amyloidosis: the state-of-the-art. Trends Cardiovasc Med 29(2):83\u201394","journal-title":"Trends Cardiovasc Med"},{"issue":"4","key":"10350_CR25","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1002\/ejhf.2140","volume":"23","author":"P Garcia-Pavia","year":"2021","unstructured":"Garcia-Pavia P, Rapezzi C, Adler Y, Arad M, Basso C, Brucato A et al (2021) Diagnosis and treatment of cardiac amyloidosis. A position statement of the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases. Eur J Heart Fail 23(4):512\u2013526","journal-title":"Eur J Heart Fail"},{"issue":"3","key":"10350_CR26","doi-asserted-by":"publisher","first-page":"1976","DOI":"10.1002\/ehf2.13909","volume":"9","author":"F Oike","year":"2022","unstructured":"Oike F, Usuku H, Yamamoto E, Marume K, Takashio S, Ishii M et al (2022) Utility of left atrial and ventricular strain for diagnosis of transthyretin amyloid cardiomyopathy in aortic stenosis. ESC Heart Fail 9(3):1976\u201386","journal-title":"ESC Heart Fail"},{"issue":"9","key":"10350_CR27","doi-asserted-by":"publisher","first-page":"1494","DOI":"10.1253\/circj.CJ-20-1064","volume":"85","author":"G Robin","year":"2021","unstructured":"Robin G, Cognet T, Bouisset F, Cariou E, M\u00e9jean S, Pradel S et al (2021) Value of longitudinal strain to identify wild-type transthyretin amyloidosis in patients with aortic stenosis. Circulation journal\u202f: Official journal of the Japanese Circulation Society 85(9):1494\u2013504","journal-title":"Circulation journal : Official journal of the Japanese Circulation Society"},{"key":"10350_CR28","doi-asserted-by":"publisher","first-page":"1108696","DOI":"10.3389\/fcvm.2023.1108696","volume":"10","author":"A Cersosimo","year":"2023","unstructured":"Cersosimo A, Bonelli A, Lombardi CM, Moreo A, Pagnesi M, Tomasoni D et al (2023) Multimodality imaging in the diagnostic management of concomitant aortic stenosis and transthyretin-related wild-type cardiac amyloidosis. Front Cardiovasc Med 10:1108696","journal-title":"Front Cardiovasc Med"},{"issue":"3","key":"10350_CR29","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1007\/s11886-018-0961-3","volume":"20","author":"PR Scully","year":"2018","unstructured":"Scully PR, Bastarrika G, Moon JC, Treibel TA (2018) Myocardial extracellular volume quantification by cardiovascular magnetic resonance and computed tomography. Curr Cardiol Rep 20(3):15","journal-title":"Curr Cardiol Rep"},{"issue":"5","key":"10350_CR30","first-page":"1600","volume":"127","author":"NG Frangogiannis","year":"2017","unstructured":"Frangogiannis NG (2017) The extracellular matrix in myocardial injury, repair, and remodeling. J\u00a0Clin\u00a0Investig 127(5):1600\u201312","journal-title":"J\u00a0Clin\u00a0Investig"},{"issue":"10","key":"10350_CR31","doi-asserted-by":"publisher","first-page":"2177","DOI":"10.1016\/j.jcmg.2020.05.029","volume":"13","author":"PR Scully","year":"2020","unstructured":"Scully PR, Patel KP, Saberwal B, Klotz E, Augusto JB, Thornton GD et al (2020) Identifying cardiac amyloid in aortic stenosis: ECV quantification by CT in TAVR patients. JACC Cardiovasc Imaging 13(10):2177\u201389","journal-title":"JACC Cardiovasc Imaging"},{"key":"10350_CR32","doi-asserted-by":"crossref","unstructured":"Tavoosi A, Brito JBO, El Mais H, Small TD, Crean AM, Chow BJW et al (2023) Dual versus single energy cardiac CT to measure extra cellular volume in cardiac amyloidosis: correlations with cardiac MRI.\u00a0IJC Heart Vasc\u00a044","DOI":"10.1016\/j.ijcha.2022.101166"},{"issue":"12","key":"10350_CR33","doi-asserted-by":"publisher","first-page":"2082","DOI":"10.1016\/j.jcmg.2022.08.006","volume":"15","author":"F Gama","year":"2022","unstructured":"Gama F, Rosmini S, Bandula S, Patel KP, Massa P, Tobon-Gomez C et al (2022) Extracellular volume fraction by computed tomography predicts long-term prognosis among patients with cardiac amyloidosis. JACC Cardiovasc Imaging 15(12):2082\u201394","journal-title":"JACC Cardiovasc Imaging"},{"issue":"7","key":"10350_CR34","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1093\/eurheartj\/ehab395","volume":"43","author":"A Vahanian","year":"2022","unstructured":"Vahanian A, Beyersdorf F, Praz F, Milojevic M, Baldus S, Bauersachs J et al (2022) 2021 ESC\/EACTS Guidelines for the management of valvular heart disease. Eur Heart J 43(7):561\u2013632","journal-title":"Eur Heart J"},{"key":"10350_CR35","doi-asserted-by":"publisher","unstructured":"Hussain M, Hanna M, Griffin BP, Conic J, Patel J, Fava AM, Watson C, Phelan DM, Jellis C, Grimm RA, Rodriguez LL, Schoenhagen P, Hachamovitch R, Jaber WA, Cremer PC, Collier P (2020) Aortic valve calcium in patients with transthyretin cardiac amyloidosis: a propensity-matched analysis. Circ Cardiovasc Imaging 13(10):e011433. https:\/\/doi.org\/10.1161\/CIRCIMAGING.120.011433. Epub 2020 Sep 23. PMID: 32967445.","DOI":"10.1161\/CIRCIMAGING.120.011433"},{"issue":"14","key":"10350_CR36","doi-asserted-by":"publisher","first-page":"2205","DOI":"10.1016\/j.jaccas.2020.10.002","volume":"2","author":"M Hussain","year":"2020","unstructured":"Hussain M, Hanna M, Rodriguez L, Griffin B, Watson C, Phelan D et al (2020) Subthreshold aortic valve calcium scores in severe aortic stenosis and transthyretin cardiac amyloidosis. JACC Case Rep 2(14):2205\u20139","journal-title":"JACC Case Rep"},{"issue":"14","key":"10350_CR37","doi-asserted-by":"publisher","first-page":"2210","DOI":"10.1016\/j.jaccas.2020.10.011","volume":"2","author":"J Ternacle","year":"2020","unstructured":"Ternacle J, Pibarot P, Clavel MA (2020) Aortic stenosis and cardiac amyloidosis: watch out for traps! JACC Case Rep 2(14):2210\u20132","journal-title":"JACC Case Rep"},{"key":"10350_CR38","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.hjc.2021.11.001","volume":"64","author":"JS Ho","year":"2022","unstructured":"Ho JS, Kor Q, Kong WK, Lim YC, Chan MY, Syn NL et al (2022) Prevalence and outcomes of concomitant cardiac amyloidosis and aortic stenosis: a systematic review and meta-analysis. Hellenic J Cardiol:\u00a0HJC = Hellenike Kardiologike Epitheorese 64:67\u201376","journal-title":"Hellenic J Cardiol:\u00a0HJC = Hellenike Kardiologike Epitheorese"},{"issue":"1","key":"10350_CR39","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1016\/j.jcmg.2020.07.011","volume":"14","author":"F Ricci","year":"2021","unstructured":"Ricci F, Ceriello L, Khanji MY, Dangas G, Bucciarelli-Ducci C, Di Mauro M et al (2021) Prognostic significance of cardiac amyloidosis in patients with aortic stenosis: a systematic review and meta-analysis. JACC Cardiovasc Imaging 14(1):293\u20135","journal-title":"JACC Cardiovasc Imaging"},{"key":"10350_CR40","doi-asserted-by":"publisher","first-page":"858281","DOI":"10.3389\/fmed.2022.858281","volume":"9","author":"VA Myasoedova","year":"2022","unstructured":"Myasoedova VA, Conte M, Valerio V, Moschetta D, Massaiu I, Petraglia L et al (2022) Red flags, prognostic impact, and management of patients with cardiac amyloidosis and aortic valve stenosis: a systematic review and meta-analysis. Front Med 9:858281","journal-title":"Front Med"},{"issue":"5","key":"10350_CR41","doi-asserted-by":"publisher","first-page":"3188","DOI":"10.1002\/ehf2.13876","volume":"9","author":"F Cannata","year":"2022","unstructured":"Cannata F, Chiarito M, Pinto G, Villaschi A, Sanz-S\u00e1nchez J, Fazzari F et al (2022) Transcatheter aortic valve replacement in aortic stenosis and cardiac amyloidosis: a systematic review and meta-analysis. ESC Heart Fail 9(5):3188\u201397","journal-title":"ESC Heart Fail"},{"issue":"29","key":"10350_CR42","doi-asserted-by":"publisher","first-page":"2759","DOI":"10.1093\/eurheartj\/ehaa170","volume":"41","author":"PR Scully","year":"2020","unstructured":"Scully PR, Patel KP, Treibel TA, Thornton GD, Hughes RK, Chadalavada S et al (2020) Prevalence and outcome of dual aortic stenosis and cardiac amyloid pathology in patients referred for transcatheter aortic valve implantation. Eur Heart J 41(29):2759\u201367","journal-title":"Eur Heart J"},{"issue":"6","key":"10350_CR43","doi-asserted-by":"publisher","first-page":"477","DOI":"10.2217\/fca-2021-0118","volume":"18","author":"D de Campos","year":"2022","unstructured":"de Campos D, Saleiro C, Botelho A, Costa M, Gon\u00e7alves L, Teixeira R (2022) Aortic valve intervention for aortic stenosis and cardiac amyloidosis: a systematic review and meta-analysis. Future Cardiol 18(6):477\u201386","journal-title":"Future Cardiol"},{"issue":"7","key":"10350_CR44","doi-asserted-by":"publisher","first-page":"e014115","DOI":"10.1161\/CIRCIMAGING.122.014115","volume":"15","author":"C Nitsche","year":"2022","unstructured":"Nitsche C, Koschutnik M, Don\u00e0 C, Radun R, Mascherbauer K, Kammerlander A et al (2022) Reverse remodeling following valve replacement in coexisting aortic stenosis and transthyretin cardiac amyloidosis. Circ Cardiovasc Imaging 15(7):e014115","journal-title":"Circ Cardiovasc Imaging"},{"issue":"16","key":"10350_CR45","doi-asserted-by":"publisher","first-page":"1554","DOI":"10.1093\/eurheartj\/ehab072","volume":"42","author":"P Garcia-Pavia","year":"2021","unstructured":"Garcia-Pavia P, Rapezzi C, Adler Y, Arad M, Basso C, Brucato A et al (2021) Diagnosis and treatment of cardiac amyloidosis: a position statement of the ESC Working Group on Myocardial and Pericardial Diseases. Eur Heart J 42(16):1554\u201368","journal-title":"Eur Heart J"},{"issue":"17","key":"10350_CR46","doi-asserted-by":"publisher","first-page":"1748","DOI":"10.1016\/j.jcin.2022.06.009","volume":"15","author":"C Don\u00e0","year":"2022","unstructured":"Don\u00e0 C, Nitsche C, Koschutnik M, Heitzinger G, Mascherbauer K, Kammerlander AA et al (2022) Unveiling cardiac amyloidosis, its characteristics, and outcomes among patients with MR undergoing transcatheter edge-to-edge MV repair. JACC Cardiovasc Interv 15(17):1748\u201358","journal-title":"JACC Cardiovasc Interv"},{"issue":"5","key":"10350_CR47","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1007\/s00392-016-1058-x","volume":"106","author":"D Mohty","year":"2017","unstructured":"Mohty D, Pradel S, Magne J, Fadel B, Boulogne C, Petitalot V et al (2017) Prevalence and prognostic impact of left-sided valve thickening in systemic light-chain amyloidosis. Clinical research in cardiology\u202f: official journal of the German Cardiac Society. 106(5):331\u201340","journal-title":"Clinical research in cardiology : official journal of the German Cardiac Society."},{"issue":"4","key":"10350_CR48","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1016\/j.carpath.2009.04.005","volume":"19","author":"AV Kristen","year":"2010","unstructured":"Kristen AV, Schnabel PA, Winter B, Helmke BM, Longerich T, Hardt S et al (2010) High prevalence of amyloid in 150 surgically removed heart valves\u2013a comparison of histological and clinical data reveals a correlation to atheroinflammatory conditions. Cardiovascular pathology\u202f: the official journal of the Society for Cardiovascular Pathology. 19(4):228\u201335","journal-title":"Cardiovascular pathology : the official journal of the Society for Cardiovascular Pathology."},{"issue":"3","key":"10350_CR49","first-page":"182","volume":"44","author":"T Yokota","year":"1994","unstructured":"Yokota T, Okabayashi H, Ishihara T, Kawano H, Wakabayashi F, Miyamoto AT et al (1994) Immunohistochemical and pathological characteristics of dystrophic amyloid in surgically excised cardiac valves. Pathol\u00a0Int 44(3):182\u20135","journal-title":"Pathol\u00a0Int"},{"issue":"8","key":"10350_CR50","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1016\/S0025-6196(12)61493-1","volume":"59","author":"TJ Smith","year":"1984","unstructured":"Smith TJ, Kyle RA, Lie JT (1984) Clinical significance of histopathologic patterns of cardiac amyloidosis. Mayo Clin\u00a0Proc 59(8):547\u201355","journal-title":"Mayo Clin\u00a0Proc"},{"issue":"3","key":"10350_CR51","first-page":"304","volume":"26","author":"A Nemes","year":"2017","unstructured":"Nemes A, F\u00f6lde\u00e1k D, Korm\u00e1nyos \u00c1, Domsik P, Kalapos A, Borb\u00e9nyi Z et al (2017) Cardiac amyloidosis associated with enlargement and functional impairment of the mitral annulus: insights from the three-dimensional speckle tracking echocardiographic MAGYAR-path study. J Heart Valve Dis 26(3):304\u20138","journal-title":"J Heart Valve Dis"},{"issue":"6","key":"10350_CR52","doi-asserted-by":"publisher","first-page":"1199","DOI":"10.1510\/icvts.2008.187179","volume":"7","author":"H Nishi","year":"2008","unstructured":"Nishi H, Mitsuno M, Ryomoto M, Miyamoto Y (2008) Severe mitral regurgitation due to cardiac amyloidosis\u2013a rare reason for ruptured chordae. Interact Cardiovasc Thorac Surg 7(6):1199\u2013200","journal-title":"Interact Cardiovasc Thorac Surg"},{"key":"10350_CR53","doi-asserted-by":"publisher","unstructured":"Aimo A, Fabiani I, Maccarana A, Vergaro G, Chubuchny V, Pasanisi EM, Petersen C, Poggianti E, Giannoni A, Spini V, Taddei C, Castiglione V, Passino C, Fontana M, Emdin M, Venneri L (2023) Valve disease in cardiac amyloidosis: an echocardiographic score. Int J Cardiovasc Imaging. https:\/\/doi.org\/10.1007\/s10554-023-02901-2. Epub ahead of print. PMID: 37341947.","DOI":"10.1007\/s10554-023-02901-2"},{"issue":"9","key":"10350_CR54","doi-asserted-by":"publisher","first-page":"1700","DOI":"10.1002\/ejhf.2606","volume":"24","author":"L Chacko","year":"2022","unstructured":"Chacko L, Karia N, Venneri L, Bandera F, Passo BD, Buonamici L et al (2022) Progression of echocardiographic parameters and prognosis in transthyretin cardiac amyloidosis. Eur J Heart Fail 24(9):1700\u201312","journal-title":"Eur J Heart Fail"},{"issue":"1","key":"10350_CR55","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1161\/CIRCULATIONAHA.118.038169","volume":"140","author":"T Lane","year":"2019","unstructured":"Lane T, Fontana M, Martinez-Naharro A, Quarta CC, Whelan CJ, Petrie A et al (2019) Natural history, quality of life, and outcome in cardiac transthyretin amyloidosis. Circulation. 140(1):16\u201326","journal-title":"Circulation."},{"issue":"1","key":"10350_CR56","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.jcmg.2021.06.022","volume":"15","author":"F Bandera","year":"2022","unstructured":"Bandera F, Martone R, Chacko L, Ganesananthan S, Gilbertson JA, Ponticos M et al (2022) Clinical importance of left atrial infiltration in cardiac transthyretin amyloidosis. JACC Cardiovasc Imaging 15(1):17\u201329","journal-title":"JACC Cardiovasc Imaging"},{"issue":"5","key":"10350_CR57","doi-asserted-by":"publisher","first-page":"732","DOI":"10.1016\/j.jaccao.2020.11.005","volume":"2","author":"M Fontana","year":"2020","unstructured":"Fontana M, Patel RK, Martinez-Naharro A (2020) Atrial involvement in cardiac amyloidosis: beyond dilatation. JACC CardioOncology. 2(5):732\u20134","journal-title":"JACC CardioOncology."},{"issue":"6","key":"10350_CR58","first-page":"e13473","volume":"51","author":"MJ Volz","year":"2021","unstructured":"Volz MJ, Pleger ST, Weber A, Geis NA, Hamed S, Mereles D et al (2021) Initial experience with percutaneous mitral valve repair in patients with cardiac amyloidosis. Eur\u00a0J\u00a0Clin\u00a0Invest 51(6):e13473","journal-title":"Eur\u00a0J\u00a0Clin\u00a0Invest"},{"issue":"9","key":"10350_CR59","first-page":"100881","volume":"47","author":"RA Thakker","year":"2022","unstructured":"Thakker RA, Elbadawi A, Albaeni A, Hasan SM, Suthar KH, Modi SA et al (2022) Percutaneous mitral valve repair in cardiac amyloidosis and severe mitral regurgitation. Curr\u00a0Probl\u00a0Cardiol 47(9):100881","journal-title":"Curr\u00a0Probl\u00a0Cardiol"},{"issue":"1","key":"10350_CR60","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1002\/ehf2.13093","volume":"8","author":"J Fagot","year":"2021","unstructured":"Fagot J, Lavie-Badie Y, Blanchard V, Fournier P, Galinier M, Carri\u00e9 D et al (2021) Impact of tricuspid regurgitation on survival in patients with cardiac amyloidosis. ESC Heart Fail 8(1):438\u201346","journal-title":"ESC Heart Fail"},{"key":"10350_CR61","first-page":"101026","volume":"40","author":"A Nemes","year":"2022","unstructured":"Nemes A, R\u00e1cz G, Korm\u00e1nyos \u00c1, F\u00f6lde\u00e1k D, Borb\u00e9nyi Z (2022) The tricuspid annulus in amyloidosis with cardiac involvement: detailed analysis from the three-dimensional speckle tracking echocardiographic MAGYAR-Path Study. Int J Cardiol Heart Vasc 40:101026","journal-title":"Int J Cardiol Heart Vasc"},{"key":"10350_CR62","doi-asserted-by":"publisher","unstructured":"Tomasoni D, Adamo M, Porcari A, Aimo A, Bonfioli GB, Castiglione V, Franzini M, Inciardi RM, Khalil A, Lombardi CM, Lupi L, Nardi M, Oriecuia C, Pagnesi M, Panichella G, Rossi M, Saccani N, Specchia C, Vergaro G, Merlo M, Sinagra G, Emdin M, Metra M (2023) Right ventricular to pulmonary artery coupling and outcome in patients with cardiac amyloidosis. Eur Heart J Cardiovasc Imaging jead145. https:\/\/doi.org\/10.1093\/ehjci\/jead145. Epub ahead of print. PMID: 37379445.","DOI":"10.1093\/ehjci\/jead145"},{"issue":"2","key":"10350_CR63","doi-asserted-by":"publisher","first-page":"1003","DOI":"10.1002\/ehf2.14262","volume":"10","author":"IA Hoerbrand","year":"2023","unstructured":"Hoerbrand IA, Volz MJ, Aus dem Siepen F, Aurich M, Schlegel P, Geis NA et al (2023) Initial experience with transcatheter tricuspid valve repair in patients with cardiac amyloidosis. ESC Heart Fail 10(2):1003\u201310012","journal-title":"ESC Heart Fail"},{"issue":"8","key":"10350_CR64","doi-asserted-by":"publisher","first-page":"1377","DOI":"10.1002\/ejhf.2504","volume":"24","author":"M Merlo","year":"2022","unstructured":"Merlo M, Pagura L, Porcari A, Cameli M, Vergaro G, Musumeci B et al (2022) Unmasking the prevalence of amyloid cardiomyopathy in the real world: results from Phase 2 of the AC-TIVE study, an Italian nationwide survey. Eur J Heart Fail 24(8):1377\u201386","journal-title":"Eur J Heart Fail"},{"issue":"Suppl B","key":"10350_CR65","doi-asserted-by":"publisher","first-page":"B79","DOI":"10.1093\/eurheartjsupp\/suad079","volume":"25","author":"M Emdin","year":"2023","unstructured":"Emdin M, Morfino P, Crosta L, Aimo A, Vergaro G, Castiglione V (2023) Monoclonal antibodies and amyloid removal as a therapeutic strategy for cardiac amyloidosis. European Heart Journal Supplements\u202f: Journal of the European Society of Cardiology 25(Suppl B):B79-b84","journal-title":"European Heart Journal Supplements\u202f: Journal of the European Society of Cardiology"},{"issue":"3","key":"10350_CR66","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1056\/NEJMoa2303765","volume":"389","author":"P Garcia-Pavia","year":"2023","unstructured":"Garcia-Pavia P, Aus dem Siepen F, Donal E, Lairez O, van der Meer P, Kristen AV et al (2023) Phase 1 trial of antibody NI006 for depletion of cardiac transthyretin amyloid. New Engl J Med 389(3):239\u2013250","journal-title":"New Engl J Med"},{"issue":"5","key":"10350_CR67","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1016\/j.jcin.2012.03.012","volume":"5","author":"F Nietlispach","year":"2012","unstructured":"Nietlispach F, Webb JG, Ye J, Cheung A, Lichtenstein SV, Carere RG et al (2012) Pathology of transcatheter valve therapy. JACC Cardiovasc Interv 5(5):582\u201390","journal-title":"JACC Cardiovasc Interv"},{"issue":"1","key":"10350_CR68","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1186\/s12968-017-0415-x","volume":"19","author":"JL Cavalcante","year":"2017","unstructured":"Cavalcante JL, Rijal S, Abdelkarim I, Althouse AD, Sharbaugh MS, Fridman Y et al (2017) Cardiac amyloidosis is prevalent in older patients with aortic stenosis and carries worse prognosis. Journal of Cardiovascular Magnetic Resonance\u202f: Official Journal of the Society for Cardiovascular Magnetic Resonance 19(1):98","journal-title":"Journal of Cardiovascular Magnetic Resonance : Official Journal of the Society for Cardiovascular Magnetic Resonance"},{"issue":"4","key":"10350_CR69","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1159\/000499933","volume":"142","author":"B Xu","year":"2019","unstructured":"Xu B, Godoy Rivas C, Rodriguez ER, Tan C, Gillinov AM, Harb S et al (2019) Unrecognized cardiac amyloidosis at the time of mitral valve surgery: incidence and outcomes. Cardiology 142(4):253\u20138","journal-title":"Cardiology"}],"container-title":["Heart Failure Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10741-023-10350-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10741-023-10350-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10741-023-10350-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,29]],"date-time":"2024-02-29T18:23:58Z","timestamp":1709231038000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10741-023-10350-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9,22]]},"references-count":69,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,1]]}},"alternative-id":["10350"],"URL":"https:\/\/doi.org\/10.1007\/s10741-023-10350-1","relation":{},"ISSN":["1573-7322"],"issn-type":[{"value":"1573-7322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,9,22]]},"assertion":[{"value":"13 September 2023","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 September 2023","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}